nitrofurantoin has been researched along with primaquine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chan, TK; Todd, D; Tso, SC | 1 |
| Waller, HD | 1 |
| Maronpot, RR | 1 |
| Lee, MS; Mia, AS; Smith, JE | 1 |
| Moxey, PC; Robles, E; Schimmel, EM; Trier, JS | 1 |
| Clancy, CF | 1 |
| Ezra, R; Sheba, C; Szeinberg, A | 1 |
| KIMBRO, EL; SACHS, MV; TORBERT, JV | 1 |
2 review(s) available for nitrofurantoin and primaquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Adverse effects of drugs in hereditary variants in the enzyme apparatus of the body].
Topics: Adenosine Triphosphatases; Adult; Aged; Cholinesterase Inhibitors; Coumarins; Dibucaine; Drug-Related Side Effects and Adverse Reactions; Female; Glutathione Reductase; Hemolysis; Humans; Isoniazid; Metabolism, Inborn Errors; Nitrofurantoin; Primaquine; Strophanthins | 1968 |
15 other study(ies) available for nitrofurantoin and primaquine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Cell Survival; China; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Nitrofurantoin; Primaquine; Stimulation, Chemical; Sulfamethoxazole; Time Factors | 1976 |
Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
Topics: Age Factors; Animals; Chromium Isotopes; Disease Models, Animal; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hemolysis; Male; Methylene Blue; Nitrofurantoin; Primaquine; Pyrimethamine; Sex Factors; Sheep | 1972 |
Decreased gamma-glutamylcysteine synthetase: the probable cause of glutathione deficiency in sheep erythrocytes.
Topics: Animals; Cell Survival; Cysteine; Erythrocytes; Glutamine; Glutathione; Hemoglobins; Nitrofurantoin; Peptide Synthases; Primaquine; Sheep | 1973 |
Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment.
Topics: Antiprotozoal Agents; Biopsy; Chloroquine; Chronic Disease; Coccidiosis; Diagnosis, Differential; Diarrhea; Diet Therapy; Drug Therapy, Combination; Duodenum; Follow-Up Studies; Humans; Intestinal Diseases, Parasitic; Intestine, Small; Isospora; Jejunum; Malabsorption Syndromes; Male; Metronidazole; Microscopy, Electron; Middle Aged; Nitrofurantoin; Primaquine; Pyrimethamine; Quinacrine; Sulfadiazine; Tetracycline; Time Factors | 1974 |
The lethal effect of certain antimalarial drugs on Tetrahymena pyriformis.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Metronidazole; Nitrofurantoin; Penicillins; Primaquine; Proguanil; Quinacrine; Quinine; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetrahymena | 1968 |
Catalase activity in normal and glucose-6-phosphate dehydrogenase deficient red cells.
Topics: Catalase; Erythrocytes; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; In Vitro Techniques; Jews; Male; Nitrofurantoin; Phenylhydrazines; Primaquine | 1965 |
Mechanism of the hemolytic anemia induced by nitrofurantoin (furadantin); further observations on the incidence and significance of primaquine-sensitive red cells.
Topics: Anemia; Anemia, Hemolytic; Antimalarials; Erythrocytes; Humans; Incidence; Nitrofurantoin; Primaquine | 1957 |